Company: CRVO
Filing Date: 2025-04-29
Form Type: DEF 14A
Source: 0001437749-25-013543
Chunk: 61

Company: CervoMed Inc.
Filing Date: 2025-04-29
Form: DEF 14A
Chunk 61
---
 transactions. |

| ● | No Reload Stock Options or Stock Appreciation Rights.  Reload stock options and stock appreciation rights are not authorized under the 2025 Plan. Reload stock options and reload stock appreciation rights are incentive awards that automatically provide for an additional grant of the same type of incentive awards upon the exercise of the incentive award. |

| ● | Stock Options, Stock Appreciation Rights and Unvested Performance Awards are Not Entitled to Dividend Equivalent Rights.  Stock option, stock appreciation right and unvested performance award holders have no rights as stockholders with respect to the shares underlying their awards until their stock options, stock appreciation rights or unvested performance awards are exercised or vested and shares are issued.  As a result, stock options and stock appreciation rights and unvested performance awards, the vesting of which is based on the achievement of performance goals, under the 2025 Plan have no dividend equivalent rights associated with them. |

| ● | No Liberal Change in Control Definition.  The change in control definition in the 2025 Plan is not a “liberal” definition and, for example, would not be activated merely upon stockholder approval of a transaction or, necessarily, upon the consummation of such a transaction. A change in control must actually occur in order for the change in control provisions in the 2025 Plan to be triggered and, in such an event, the Board and the Compensation Committee have the discretion to determine whether outstanding awards continue on substantially similar terms or are terminated in exchange for payment of an amount equal to the consideration payable in such transaction. |

| ● | No Tax Gross-Ups.  The 2025 Plan does not provide for any tax gross-ups. |

| ● | Material Amendments Require Stockholder Approval.  The 2025 Plan requires stockholder approval of material revisions to the 2025 Plan. |

| ● | Administration by Independent Committee.  The 2025 Plan will be administered by the Compensation Committee.  All members of the committee administering the 2025 Plan will be “non-employee directors” within the meaning of Rule 16b-3 under the Exchange Act and “independent directors” under the Listing Rules of Nasdaq (or other applicable exchange or market on which our common stock may be traded or quoted) and any applicable rules and regulations of the SEC. |

| ● | Awards Subject to Forfeiture/Clawback.  The 2025 Plan contains a forfeiture or “clawback” provision, which, provides